Prothena Corp PLC (PRTA)
47.07
-1.00 (-2.08%)
USD |
NASDAQ |
Mar 24, 16:00
48.01
+0.94 (+2.00%)
After-Hours: 20:00
Prothena Profit Margin (Quarterly): 12.72% for Dec. 31, 2022
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 12.72% |
| September 30, 2022 | -3.02K% |
| June 30, 2022 | -3.14K% |
| March 31, 2022 | -3.15K% |
| December 31, 2021 | -2.83K% |
| September 30, 2021 | 78.50% |
| June 30, 2021 | 46.02% |
| March 31, 2021 | -22.96K% |
| December 31, 2020 | -8.53K% |
| September 30, 2020 | -19.48K% |
| June 30, 2020 | -13.48K% |
| March 31, 2020 | -16.72K% |
| December 31, 2019 | -8.42K% |
| September 30, 2019 | -9.49K% |
| June 30, 2019 | -9.47K% |
| March 31, 2019 | -11.22K% |
| December 31, 2018 | -11.58K% |
| September 30, 2018 | -9.63K% |
| June 30, 2018 | -21.46K% |
| March 31, 2018 | -21.47K% |
| December 31, 2017 | -20.86K% |
| September 30, 2017 | -23.92K% |
| Date | Value |
|---|---|
| June 30, 2017 | -66.02% |
| March 31, 2017 | -13.66K% |
| December 31, 2016 | -28.60K% |
| September 30, 2016 | -15.12K% |
| June 30, 2016 | -12.15K% |
| March 31, 2016 | -10.39K% |
| December 31, 2015 | -7.87K% |
| September 30, 2015 | -5.36K% |
| June 30, 2015 | -6.57K% |
| March 31, 2015 | -2.56K% |
| December 31, 2014 | -651.3% |
| September 30, 2014 | -887.1% |
| June 30, 2014 | 8.53% |
| March 31, 2014 | 55.38% |
| December 31, 2013 | -6.62K% |
| September 30, 2013 | -5.67K% |
| June 30, 2013 | -6.77K% |
| March 31, 2013 | -5.23K% |
| December 31, 2012 | -2.13K% |
| September 30, 2012 | -918.2% |
| June 30, 2012 | -1.32K% |
| March 31, 2012 | -2.68K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-22.96K%
Minimum
Mar 2021
78.50%
Maximum
Sep 2021
-9.79K%
Average
-9.48K%
Median
Profit Margin (Quarterly) Benchmarks
| Mallinckrodt PLC | -54.54% |
| Jazz Pharmaceuticals PLC | -24.76% |
| Nabriva Therapeutics PLC | -131.1% |
| Iterum Therapeutics PLC | -- |
| GH Research PLC | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -25.00% |
| Return on Assets | -19.15% |
| Return on Invested Capital | -25.00% |
| Operating Margin (Quarterly) | -0.14% |
| Return on Net Operating Assets | -864.9% |